GlassScriptPhysician profile
Victoria Scala
NPI 1285096255
$5,476.84
in general payments reported to CMS, 2019-2025
14 companies · $2,838 in 2025
The $2,838 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,639 · 2025: $2,838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,934 · Food and Beverage: $2,543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,933.78 |
| Food and Beverage | $2,543.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,702.99 | 2024-2025 | Motoband, Na |
| Arthrex, INC. | $1,680.49 | 2024-2025 | |
| Paragon 28, INC. | $541.65 | 2025 | Additive Orthopedics |
| Depuy Synthes Sales INC. | $336.68 | 2024-2025 | Na, Motoband |
| Elevate Surgical Co | $305.41 | 2024-2025 | |
| Tricoast Surgical Solutions LLC | $210.66 | 2024 | |
| Stryker Corporation | $146.06 | 2024 | Inbone |
| Orthofix Medical, INC. | $122.70 | 2025 | Physio-Stim |
| Medline Industries LP | $117.56 | 2025 | |
| Trimed, INC. | $102.04 | 2025 | |
| Bioventus LLC | $86.20 | 2024 | None |
| Skeletal Dynamics INC | $79.60 | 2025 | Ijs, Geminus, Implate |
| Vertex Pharmaceuticals Incorporated | $24.66 | 2025 | |
| Solventum Corporation | $20.14 | 2025 | V.A.C. Dermatac, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Scala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.